Skip to main content
. 2022 Sep 17;66(1):213–222. doi: 10.1007/s00125-022-05790-7

Table 1.

Characteristics of the overall study population and the population stratified according to type 2 diabetes status

Variable Overall
(n=1554)
Individuals without type 2 diabetes
(n=1185)
Individuals with type 2 diabetes
(n=369)
Age, years 60 ± 8 59 ± 8 62 ± 8
Sex, % women 47.9 53.8 29.0
Postmenopausal, % of women 79.2 78.3 84.1
Use of oestrogen-containing medication, % of women 4.0 3.8 5.6
Education level low/medium/high, % 30.3/28.8/40.9 27.3/28.4/44.2 39.8/30.1/30.1
Smoking, never/former/current, % 38.0/50.2/11.8 39.0/49.3/11.7 34.8/53.0/12.2
DHD index (DHD-13)a 77.2 ± 13.9 78.0 ± 13.9 74.8 ± 13.7
Alcohol, g/day 9.0 (2.0–19.0) 9.8 (2.7–19.5) 5.8 (0.5–16.0)
Physical activity, min/day 120.8 (93.6–148.7) 125.5 (101.1–152.5) 100.9 (74.6–135.8)
BMI, kg/m2 26.6 ± 4.1 25.8 ± 3.7 29.0 ± 4.3
Waist circumference, cm 94.3 ± 12.5 91.3 ± 11.0 103.8 ± 12.5
Office systolic blood pressure, mmHg 134 ± 17 132 ± 17 140 ± 16
Office diastolic blood pressure, mmHg 76 ± 10 76 ± 10 77 ± 9
Total cholesterol, mmol/l 5.3 ± 1.2 5.6 ± 1.1 4.5 ± 1.0
HDL-cholesterol, mmol/l 1.6 ± 0.5 1.7 ± 0.5 1.3 ± 0.4
LDL-cholesterol, mmol/l 3.1 ± 1.0 3.3 ± 1.0 2.4 ± 0.9
Triglycerides, mmol/l 1.2 (0.9–1.7) 1.1 (0.8–1.5) 1.5 (1.1–2.1)
Use of lipid-modifying medication, % 32.3 19.7 72.9
HbA1c, % 5.6 (5.4–6.0) 5.4 (5.3–5.7) 6.7 (6.2–7.4)
HbA1c, mmol/mol 38.0 (35.0–42.0) 36.0 (34.0–39.0) 50.0 (44.5–57.0)
Fasting glucose, mmol/l 5.5 (5.0–6.3) 5.3 (4.9–5.7) 7.5 (6.8–8.6)
Fasting insulin, mmol/l 59.1 (41.8–87.8) 55.3 (40.0–77.0) 83.2 (51.3–126.0)
Matsuda index 3.6 (2.1–5.3) 4.1 (2.6–5.8) 2.0 (1.3–3.0)
Use of glucose-lowering medication, % 17.9 0.0 75.3
IHL content, % 3.5 (2.1–6.5) 2.9 (1.9–5.1) 5.2 (3.5–10.7)
Hepatic steatosis, % yes 29.9 22.0 55.0
Serum SHBG, nmol/l 35.5 (25.3–49.8) 38.7 (27.6–54.2) 26.4 (19.6–37.0)

Data are presented as mean ± SD or median (IQR) unless otherwise indicated

aDutch Healthy Diet (DHD-14) index minus alcohol component (DHD-13)